Buscar resultados de ensayos clínicos
Lymphoma, Mantle-Cell - 25 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Study Of Yttrium-ibritumomab (Zevalin) For the Treatment Of Patients With Relapsed And Refractory Mantle Cell Lymphoma Condición: Lymphoma, Mantle-Cell Fecha: 2002-06-03 Intervenciones:
|
Completed |
Nombre del estudio: Dexamethasone, Ofatumumab and Bendamustine (DOT) First-line in Mantle-cell Lymphoma(MCL) Condición: Lymphoma, Mantle-Cell Fecha: 2010-10-13 Intervenciones: Drug: Combination of dexamethasone, ofatumumab and bendamustine |
Completed |
Nombre del estudio: An Investigational Study Drug, Palbociclib (PD-0332991), Is Being Studied In Patients With Mantle Cell Lymphoma. Patients Must Have Received Prior Treatment(s) For Mantle Cell Lymphoma. Condición: Lymphoma, Mantle-Cell Fecha: 2007-01-05 Intervenciones: Drug: PD-0332991 125 mg, oral, Days 1-21 of a 28-day cycle |
Completed |
Nombre del estudio: Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Participants With Relapsed or Refractory Mantle Cell Lymphoma Condición: Lymphoma, Mantle-cell Fecha: 2014-06-19 Intervenciones: Drug: Ibrutinib Participants will receive ibrutinib capsules 560 milligram (mg) orally, once daily on a |
Completed |
Nombre del estudio: Immunochemotherapy With Rituximab-Bendamustine-Cytarabine (R-BAC) for Patients With Mantle Cell Lymphoma Condición: Lymphoma, Mantle-Cell Fecha: 2009-10-07 Intervenciones: Drug: Rituximab, Bendamustine, Cytarabine Rituximab IV 375 |
Completed |
Nombre del estudio: Safety and Efficacy of RAD001 in Patients With Mantle Cell Lymphoma Who Are Refractory or Intolerant to Velcade® Therapy. Condición: Lymphoma, Mantle- Cell Fecha: 2008-06-19 Intervenciones: Drug: RAD001 |
Completed |
Nombre del estudio: Observational Study of Lenalidomide in Subjects With Mantle Cell Lymphoma Who Failed Ibrutinib Treatment Condición: Lymphoma, Mantle-Cell Fecha: 2015-01-14 |
Recruiting |
Nombre del estudio: A Study of Bendamustine and Rituximab Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated Mantle Cell Lymphoma Condición: Lymphoma, Mantle Cell Fecha: 2016-11-21 Intervenciones:
|
Not yet recruiting |
Nombre del estudio: Study of Bortezomib (BTZ) Treatment on Mantle Cell Lymphoma (MCL) in Chinese Participants Condición: Lymphoma, Mantle-Cell Fecha: 2017-02-10 |
Completed |
Nombre del estudio: Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody Plus CHOP For Untreated Mantle Cell Lymphoma Condición: Lymphoma, Mantle-Cell Fecha: 2009-10-08 Intervenciones: Biological: Tositumomab and Iodine I 131 Tositumomab followed by CHOP Patients will receive an infusion |